Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-Year follow-up

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 5, 2009, Pages 573-578

  Bianchi, Stefano ^a   Ricci, Renato P ^b   Biscione, Francesco ^c   Sgreccia, Fabrizio ^a   Di Belardino, Natale ^d   Rossi, Pietro ^e   Giuli, Silvia ^f   Grammatico, Andrea ^f   De Santo, Tiziana ^f   Santi, Elisabetta ^f   Merico, Monica ^f   Piccirillo, Gianfranco ^g   Azzolini, Paolo ^a   Santini, Massimo ^b   Puglisi, Andrea ^a  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c San Giacomo Hospital   (Italy)

^d Ospedale di Velletri   (Italy)

^e BELCOLLE HOSPITAL   (Italy)

^f Medtronic Italia   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Arrhythmias; ICD testing; Implantable cardioverter defibrillator; Implantation

Indexed keywords

ADULT; AGED; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATION THRESHOLD TESTING; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEALTH CENTER; HEART EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIMARY PREVENTION; SUDDEN DEATH;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DIFFERENTIAL THRESHOLD; ELECTRIC COUNTERSHOCK; EQUIPMENT FAILURE ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; PERIOPERATIVE CARE; PRIMARY PREVENTION; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 65649083360     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02329.x     Document Type: Article

References (33)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al., Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996 335 : 1933 1940. (Pubitemid 26428217)
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
3. Task force members for the diagnosis and treatment of chronic heart failure of European Heart Association: Guideline for the Diagnosis and Treatment: (full text) of Chronic Heart Failure (2005 guideline). Eur Heart J 2005 26 : 384 416. (Pubitemid 40283098)
4. Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. Clinical experience, complications and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation 1985 71 : 289 296. (Pubitemid 15157089)
5. Marchlinski FE, Flores BT, Buxton AE, Hargrove WC III., Addonizio VP, Stephenson LW, Harken AH, et al. The automatic implantable cardioverter- defibrillator: Efficacy, complications, and device failures. Ann Intern Med 1986 104 : 481 488. (Pubitemid 16137807)
6. Bardy GH, Ivey TD, Allen MD, Johnson G, Mehra R, Greene HL. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol 1989 14 : 728 733. (Pubitemid 19229352)
7. Zipes DP, Roberts D. The Pacemaker-Cardioverter-Defibrillator Investigators. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. Circulation 1995 92 : 59 65.
8. Brady PA, Friedman PA, Trusty JM, Grice S, Hammill SC, Stanton MS. High failure rate for an epicardial implantable cadioverter-defibrillator lead: Implication for long-term follow-up of patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol 1998 31 : 616 622. (Pubitemid 28144130)
9. Singer I, Lang D. Defibrillation threshold: Clinical utility and therapeutic implications. Pacing Clin Electrophysiol 1992 15 : 932 949.
10. Strickberger SA, Daoud EG, Davidson T, Weiss R, Bogun F, Knight BP, Bahu M, et al. Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation 1997 96 : 1217 1223. (Pubitemid 27344226)
11. Strickberger SA, Klein GJ. Is defibrillator testing required for defibrillator implantation? J Am Coll Cardiol 2004 44 : 88 91. (Pubitemid 38968463)
12. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, et al. Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005 2 : 456 461. (Pubitemid 40521355)
13. Tokano T, Bach D, Chang J, Davis J, Souza JJ, Zivin A, Knight BP, et al. Effect of ventricular shock strength on cardiac haemodynamics. J Cardiovasc Electrophysiol 1998 9 : 791 797. (Pubitemid 28389924)
14. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, Krahn A, et al. Complication associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm 2008 5 : 391 393.
15. Vlay SC. Defibrillation threshold testing: Necessary but evil? Am Heart J 1989 117 : 499 504. (Pubitemid 19059809)
16. Runsiö M, Kallner A, Kallner G, Rosenqvist M, Bergfeldt L. Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release. Am J Cardiol 1997 79 : 1241 1245. (Pubitemid 27255171)
17. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter-defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005 28 : 926 932. (Pubitemid 43960867)
18. Stix G, Hirschl M, Vukovich T, Oschatz E, Kofler J, Mayer C, Kastner J, et al. Myocardial cell damage after repeated ICD therapies demonstrated by circulating cardiac specific proteins. PACE 1998 21 : 910.
19. Hinkle LE Jr., Thaler HT. Clinical classification of cardiac death. Circulation 1982 65 : 457 464.
20. Schuger C, Ellenbogen KA, Faddis M, Knight BP, Yong P, Sample R., VENTAK CHF/CONTAK CD Study Investigators. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006 17 : 247 250. (Pubitemid 43344931)
21. Gasparini M, Galimberti P, Regoli F, Ceriotti C, Bonadies M. Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): A reliable and safe approach. J Cardiovasc Electrophysiol 2005 16 : 1279 1283. (Pubitemid 43919967)
22. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, et al. PainFREE Investigators: Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001 104 : 796 801. (Pubitemid 32762678)
23. Zipes DP, Jackman WM, Heger JJ, Chilson DA, Browne KF, Naccarelli GV, Rahilly GT, et al. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: Low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 1982 103 : 789 794. (Pubitemid 13138014)
24. Swerdlow CD, Peter CT, Kass RM, Gang ES, Mandel WJ, Hwang C, Martin DJ, et al. Programming of implantable cardioverter-defibrillator on the basis of the upper limit of vulnerability. Circulation 1997 95 : 1497 1504. (Pubitemid 27142808)
25. Green UB, Garg A, Al-Kandari F, Ungab G, Tone L, Feld GK. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing. J Interv Card Electrophysiol 2003 8 : 71 75. (Pubitemid 36356176)
26. Gold MR, Higgins S, Klein R, Gilliam FR, Kopelman H, Hessen S, Payne J, et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: Primary results from the Low Energy Safety Study (LESS). Circulation 2002 105 : 2043 2048. (Pubitemid 34465266)
27. Swerdlow CD. Reappraisal of implant testing of implantable cardioverter-defibrillators. J Am Coll Cardiol 2004 44 : 92 94. (Pubitemid 38968464)
28. Chapman PD, Sagar KB, Wetherbee JN, Troup PJ. Relationship of left ventricular mass to defibrillation threshold for the implantable defibrillator: A combined clinical and animal study. Am Heart J 1987 114 : 274 278. (Pubitemid 17131721)
29. Huang J, Rogers JM, Killingsworth CR, Walcott GP, KenKnight BH, Smith WM, Ideker RE. Improvement of defibrillation efficacy and quantification of activation patterns during ventricular fibrillation in a canine heart failure model. Circulation 2001 103 : 1473 1478. (Pubitemid 32220643)
30. Reiter MJ, Landers M, Zetelaki Z, Kirchhof CJ, Allessie MA. Electrophysiological effects of acute dilatation in the isolated rabbit heart: Cycle length-dependent effects on ventricular refractoriness and conduction velocities. Circulation 1997 96 : 4050 4056. (Pubitemid 27506065)
31. Hu H, Sachs F. Stretch-activated ion channels in the heart. J Mol Cell Cardiol 1997 29 : 1511 1523. (Pubitemid 27270223)
32. Trajanova N, Li W, Eason J, Kohl P. Effects of stretch-activated channels on defibrillation efficacy. Heart Rhythm 2004 1 : 67 77. (Pubitemid 38647254)
33. Markowitz SM. To test or not to test during defibrillator implantation? A reassessment of the conventional wisdom. J Cardiovasc Electrophysiol 2008 19 : 406 408.